Alternating Chemotherapy with Cyclophosphamide/Adriamycin/Vincristine (CAV) and Cisplatin/Etoposide (PVP) against Small Cell Lun
Managing Patients With Relapsed Small-Cell Lung Cancer | JCO Oncology Practice
Downregulation of caveolin-1 increases the sensitivity of drug-resistant colorectal cancer HCT116 cells to 5-fluorouracil
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions - Megyesfalvi - 2023 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Salvage Chemotherapy with Ccnu and Methotrexate for Small Cell Lung Cancer Resistant to Cav/Pe Alternating Chemotherapy
Small Cell Lung Cancer Palak Desai, MD. - ppt download
Small-cell lung cancer: on the road to improved efficacy and tolerability - memoinOncology
Management of lung cancer - ScienceDirect
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial - The Lancet Respiratory Medicine
Cancers | Free Full-Text | Second-Line Treatment Options for Small-Cell Lung Cancer: A Light at the End of the Tunnel
PDF] A national survey of the chemotherapy regimens used to treat small cell lung cancer (SCLC) in the United Kingdom | Semantic Scholar
MAIN-CAV Trial Investigates Maintenance Cabozantinib plus Avelumab in Metastatic Urothelial Cancer – Consult QD
Current Oncology | Free Full-Text | Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer
ASCO 2023: MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab Versus Avelumab After First-Line Platinum-Based Chemotherapy in Patients with Metastatic Urothelial Cancer
ASCO 2023: MAIN-CAV: Phase III Randomized Trial of Maintenance Cabozantinib and Avelumab Versus Avelumab After First-Line Platinum-Based Chemotherapy in Patients with Metastatic Urothelial Cancer